Co-Authors
This is a "connection" page, showing publications co-authored by Magdalena Sobieszczyk and Jason Zucker.
Connection Strength
3.587
-
Supervised Machine Learning Approach to Identify Early Predictors of Poor Outcome in Patients with COVID-19 Presenting to a Large Quaternary Care Hospital in New York City. J Clin Med. 2021 Aug 11; 10(16).
Score: 0.961
-
Missed Opportunities for Engagement in the Prevention Continuum in a Predominantly Black and Latino Community in New York City. AIDS Patient Care STDS. 2018 11; 32(11):432-437.
Score: 0.793
-
Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series. BMJ Open. 2021 06 02; 11(6):e049488.
Score: 0.237
-
What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak. PLoS One. 2021; 16(4):e0249349.
Score: 0.235
-
At-Home Testing for Sexually Transmitted Infections During the COVID-19 Pandemic. Sex Transm Dis. 2021 01; 48(1):e11-e14.
Score: 0.230
-
Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019. Clin Infect Dis. 2020 11 19; 71(16):2294-2297.
Score: 0.229
-
Cycle Thresholds Among Solid Organ Transplant Recipients Testing Positive for SARS-CoV-2. Transplantation. 2021 07 01; 105(7):1445-1448.
Score: 0.060
-
Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections. Open Forum Infect Dis. 2021 Jun; 8(6):ofab201.
Score: 0.059
-
Clinical Outcomes Associated With Methylprednisolone in Mechanically Ventilated Patients With COVID-19. Clin Infect Dis. 2021 05 04; 72(9):e367-e372.
Score: 0.059
-
Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic. JAMA Netw Open. 2021 04 01; 4(4):e216842.
Score: 0.059
-
Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019. Antimicrob Agents Chemother. 2021 03 18; 65(4).
Score: 0.058
-
HIV-1 Infection Does Not Change Disease Course or Inflammatory Pattern of SARS-CoV-2-Infected Patients Presenting at a Large Urban Medical Center in New York City. Open Forum Infect Dis. 2021 Feb; 8(2):ofab029.
Score: 0.058
-
Pretest Symptom Duration and Cycle Threshold Values for Severe Acute Respiratory Syndrome Coronavirus 2 Reverse-Transcription Polymerase Chain Reaction Predict Coronavirus Disease 2019 Mortality. Open Forum Infect Dis. 2021 Feb; 8(2):ofab003.
Score: 0.058
-
Disease Course and Outcomes of COVID-19 Among Hospitalized Patients With Gastrointestinal Manifestations. Clin Gastroenterol Hepatol. 2021 07; 19(7):1402-1409.e1.
Score: 0.057
-
Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort. Hepatology. 2020 09; 72(3):807-817.
Score: 0.056
-
Clinical Performance of SARS-CoV-2 Molecular Tests. J Clin Microbiol. 2020 Jul 23; 58(8).
Score: 0.056
-
Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City. J Clin Microbiol. 2020 Jul 23; 58(8).
Score: 0.056
-
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020 05 29; 369:m1996.
Score: 0.055
-
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020 06 18; 382(25):2411-2418.
Score: 0.055
-
Gastrointestinal Symptoms and Coronavirus Disease 2019: A Case-Control Study From the United States. Gastroenterology. 2020 Jul; 159(1):373-375.e2.
Score: 0.055
-
Attitudes, practices and perceived barriers to hepatitis C screening among medical residents at a large urban academic medical center. J Viral Hepat. 2019 11; 26(11):1355-1358.
Score: 0.052
-
Adolescent Preexposure Prophylaxis Administration: An Education Curriculum for Health Care Providers. J Pediatr Health Care. 2019 May - Jun; 33(3):288-295.
Score: 0.050